Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRX

$36.40

Updated: 05/11/2026, 00:00:39

Market Cap
$1.45B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US

No historical data available

Company Profile

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.

USD
NASDAQ
CEO: Frank D. Lee
Employees: 827
https://www.pacira.com
Asset Summaries
Latest generated summaries for PCRX

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for PCRX.
Share price
$36.40
Market cap
$1.45B
Exchange
NASDAQ
Currency
USD
CEO
Frank D. Lee
Employees
827
IPO date
03/02/2011
Beta
0.252
Last dividend
$0.00
Day range
$36.38 – $36.45
52-week range
$18.80 – $36.67
1-day performance
0.03%
1-year performance
93.62%
Current drawdown (1Y)
-0.74%
CIK
0001396814
CUSIP
695127100
ISIN
US6951271005
Created
07/12/2025, 05:41:57
Last update
05/11/2026, 00:00:39

Track Pacira BioSciences, Inc. with an AI analyst

See which prediction-market events move PCRX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to PCRX from your Railway `news_articles` table.

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting

PRNewsWire • STOCK • 09/06/2026, 19:53:00

Pacira BioSciences, Inc. (PCRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 08/06/2026, 17:28:29

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

PRNewsWire • STOCK • 01/06/2026, 18:50:00

PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results

GlobeNewsWire • STOCK • 01/06/2026, 11:00:00

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira's Director Nominees

GlobeNewsWire • STOCK • 28/05/2026, 18:20:00

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees

GlobeNewsWire • STOCK • 27/05/2026, 18:20:00

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

GlobeNewsWire • STOCK • 27/05/2026, 10:00:00

PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario

GlobeNewsWire • STOCK • 25/05/2026, 11:27:00

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders

GlobeNewsWire • STOCK • 20/05/2026, 08:30:00

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

GlobeNewsWire • STOCK • 13/05/2026, 10:00:00

Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees

GlobeNewsWire • STOCK • 12/05/2026, 18:01:00

Pacira BioSciences Mails Letter to Stockholders

GlobeNewsWire • STOCK • 05/05/2026, 18:20:00